scholarly journals BRCA1 exon 11 a model of long exon splicing regulation

RNA Biology ◽  
2014 ◽  
Vol 11 (4) ◽  
pp. 351-359 ◽  
Author(s):  
Michela Raponi ◽  
Lindsay D Smith ◽  
Marco Silipo ◽  
Cristiana Stuani ◽  
Emanuele Buratti ◽  
...  
2020 ◽  
Author(s):  
John J Krais ◽  
Emma Clausen ◽  
Vladimir Khazak ◽  
Igor Astsaturov ◽  
Clare L Scott ◽  
...  

PLoS ONE ◽  
2012 ◽  
Vol 7 (5) ◽  
pp. e37255 ◽  
Author(s):  
Michela Raponi ◽  
Andrew G. L. Douglas ◽  
Claudia Tammaro ◽  
David I. Wilson ◽  
Diana Baralle

2021 ◽  
Author(s):  
Gorka Ruiz de Garibay ◽  
Ignacio Fernandez‐Garcia ◽  
Sylvie Mazoyer ◽  
Flavia Leme de Calais ◽  
Pietro Ameri ◽  
...  

2014 ◽  
Vol 15 (7) ◽  
pp. 13045-13059 ◽  
Author(s):  
Claudia Tammaro ◽  
Michela Raponi ◽  
David Wilson ◽  
Diana Baralle

Cancers ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3195
Author(s):  
Jagyeong Oh ◽  
Yongchao Liu ◽  
Namjeong Choi ◽  
Jiyeon Ha ◽  
Davide Pradella ◽  
...  

CD44 is a transmembrane glycoprotein involved in cell–cell and cell–matrix interactions. Several CD44 protein isoforms are generated in human through alternative splicing regulation of nine variable exons encoding for the extracellular juxta-membrane region. While the CD44 splicing variants have been described to be involved in cancer progression and development, the regulatory mechanism(s) underlying their production remain unclear. Here, we identify Tra2β and SRSF9 as proteins with opposite roles in regulating CD44 exon v10 splicing. While Tra2β promotes v10 inclusion, SRSF9 inhibits its inclusion. Mechanistically, we found that both proteins are able to target v10 exon, with GAAGAAG sequence being the binding site for Tra2β and AAGAC that for SRSF9. Collectively, our data add a novel layer of complexity to the sequential series of events involved in the regulation of CD44 splicing.


2012 ◽  
Vol 40 (4) ◽  
pp. 768-772 ◽  
Author(s):  
Claudia Tammaro ◽  
Michela Raponi ◽  
David I. Wilson ◽  
Diana Baralle

BRCA1 (breast cancer early-onset 1) alternative splicing levels are regulated in a cell-cycle- and cell-type-specific manner, with splice variants being present in different proportions in tumour cell lines as well as in normal mammary epithelial cells. The importance of this difference in the pathogenesis of breast cancer has yet to be determined. Developing an understanding of the impact of BRCA1 isoform ratio changes on cell phenotype will be of value in breast cancer and may offer therapeutic options. In the present paper, we describe the splicing isoforms of BRCA1 exon 11, their possible role in cancer biology and the importance of maintaining a balanced ratio.


1999 ◽  
Vol 3 (3) ◽  
pp. 389-395 ◽  
Author(s):  
Xiaoling Xu ◽  
Zoë Weaver ◽  
Steven P Linke ◽  
Cuiling Li ◽  
Jessica Gotay ◽  
...  

2019 ◽  
Author(s):  
M. Enculescu ◽  
S. Braun ◽  
S. T. Setty ◽  
K. Zarnack ◽  
J. König ◽  
...  

ABSTRACTAlternative splicing is a key step in eukaryotic gene expression that allows the production of multiple protein isoforms from the same gene. Even though splicing is perturbed in many diseases, we currently lack insights into regulatory mechanisms promoting its precision and efficiency. We analyse high-throughput mutagenesis data obtained for an alternatively spliced exon in the proto-oncogene RON and determine the functional units that control this splicing event. Using mathematical modeling of distinct splicing mechanisms, we show that alternative splicing is based in RON on a so-called ‘exon definition’ mechanism. Here, the recognition of the adjacent exons by the spliceosome is required for removal of an intron. We use our model to analyze the differences between the exon and intron definition scenarios and find that exon definition is crucial to prevent the accumulation of deleterious, partially spliced retention products during alternative splicing regulation. Furthermore, it modularizes splicing control, as multiple regulatory inputs are integrated into a common net input, irrespective of the location and nature of the corresponding cis-regulatory elements in the pre-mRNA. Our analysis suggests that exon definition promotes robust and reliable splicing outcomes in RON splicing.SIGNIFICANCEDuring mRNA maturation, pieces of the pre-mRNA (introns) are removed during splicing, and remaining parts (exons) are joined together. In alternative splicing, certain exons are either included or excluded, resulting in different splice products. Inclusion of RON alternative exon 11 leads to a functional receptor tyrosine kinase, while skipping results in a constitutively active receptor that promotes epithelial-to-mesenchymal transition and contributes to tumour invasiveness. Intron retention results in to deleterious isoforms that cannot be translated properly. Using kinetic modeling, we investigate the combinatorial regulation of this important splicing decision, and find that the experimental data supports a so-called exon definition mechanism. We show that this mechanism enhances the precision of alternative splicing regulation and prevents the retention of introns in the mature mRNA.


2008 ◽  
Vol 6 (9) ◽  
pp. 102
Author(s):  
A. Mitkova ◽  
R. Dodova ◽  
A. Vlahova ◽  
T. Dikov ◽  
T. Sedloev ◽  
...  

Oncogene ◽  
2003 ◽  
Vol 22 (4) ◽  
pp. 528-537 ◽  
Author(s):  
Richard Bachelier ◽  
Xiaoling Xu ◽  
Xaoyan Wang ◽  
Wenmei Li ◽  
Mayumi Naramura ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document